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Abstract: Serum fatty acids are increasingly used in cross-sectional surveys and cohort 
studies  as  biomarkers  of  dietary  fat  intake;  however,  it  is  currently  difficult  to  judge 
whether an individual has low or high fatty acid status, or whether the distribution of fatty 
acids of a group of people is low or high due to a lack of appropriate reference values. In 
the absence of interpretive criteria, the distribution of serum fatty acids from a suitable 
reference population can be used as an alternative. We describe the distribution of the fatty 
acid composition of the three most commonly reported lipid classes in serum; cholesterol 
ester, phospholipid and triacylgycerol. Results for each serum lipid class are presented as 
means  (SD)  and  percentiles  (5,  10,  25,  50,  75,  90,  and  95)  of  serum  fatty  acids  in  
non-fasting  blood  samples  collected  from  a  population  based  cross-sectional  survey  of 
New Zealand adults (n = 2793). These serum fatty acid reference ranges are applicable and 
relevant to Australia, United Kingdom, and United States as well as other countries where 
fat intakes are similar to New Zealand. 
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1. Introduction  
The nutritional status of populations is normally assessed using a range of dietary, anthropometric 
and biochemical measurements. Interpretive criteria for these measures are used to judge the adequacy 
of nutritional status. Cutpoints or reference values which define the stages of deficiency, insufficiency, 
adequacy, or excess are the most common interpretive criteria. However, when scientific evidence is 
insufficient  to  establish  cutpoints  for  a  particular  measurement,  the  distribution  range  of  the 
measurement in the population can be used to judge if status is high or low for individuals or groups. 
A number of serum fatty acids are valid biomarkers of dietary fat intake, and their measurement is 
becoming a complementary tool in nutrition surveys to monitor the types of fats consumed and in 
prospective studies designed to generate knowledge about the relation between various types of dietary 
fat and disease risk [1]. Unfortunately, there is little in the way of interpretive criteria or distribution 
reference  ranges  to  judge  serum  fatty  acid  status  of  the  individual.  In  general,  serum  fatty  acid 
composition, given as the molecular percentage of total fatty acids (mol%), or as a weight percent, 
tends to be reported as mean and standard deviation. We have previously reviewed and summarised 
this literature [1]; however, virtually all of the results came from studies in which the participants were 
not randomly selected from the population, thus, there is a need for data which can be generalised to 
national populations. 
The usefulness of representative population-based serum fatty acid data reported as percentiles is 
obvious because it will enable researchers and epidemiologists to evaluate and judge what constitutes 
high or low fatty acid status. For example, what constitutes a high or low value for serum linoleic acid, 
the predominant polyunsaturated serum fatty acid, or serum myristic acid, a marker of dairy fat intake 
in a reference population? 
In this paper we report the percentiles of serum phospholipid, cholesterol ester, and triacylglycerol 
fatty acids from a nation-wide representative survey of New Zealand adults. 
2. Methods  
2.1. Survey Methods 
All participants in the New Zealand 1997 National Nutrition survey (NNS97) were recruited from 
the 1996/1997 New Zealand Health Study (NZHS). Ethical approval for the surveys was obtained 
from the 14 ethics committees throughout New Zealand, and all participants (or the guardians of those 
less than 18 years old) gave informed written consent. The methodology for both surveys has been 
described in detail elsewhere [2–4]. Briefly, a three stage stratified design was used in the 1996/1997 
NZHS. New Zealand was divided into 18,880 small geographical areas. These primary sampling units 
(PSU) were divided into 122 strata, based on various geographical and socioeconomic characteristics. 
The first stage of the survey involved selection of PSUs. Secondly, households within the PSUs were 
randomly chosen. Finally, one eligible adult from the chosen household was randomly selected to Nutrients 2011, 3  
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participate in the NZHS. All participants who consented to participate in the 1996/1997 NZHS were 
invited to participate in the NNS97 which was to follow several months later than the NZHS. Those 
who consented to participate in NNS97 were interviewed in their homes. During the home-interview, 
height and weight were measured, and body mass index (BMI, kg/m
2) calculated. Smoking status 
and ethnicity  were  self-reported.  Also  during  this  interview,  NNS97  participants  completed  a 
computer-assisted  24  h  dietary  recall,  and  were  asked  to  provide  a  blood  sample.  The  NNS97 
participants were not asked to fast before the blood sample was collected. Blood was taken into a 
10 mL vacuum evacuated tube with no anticoagulant and tubes immediately placed in a polystyrene 
container which contained an ice pack. The container was sent on the same day to a laboratory for 
processing and storage of serum. Serum was stored at −80 °C  until the fatty acid analysis. 
2.2. Serum Fatty Acid Analysis 
Serum lipids were extracted according to the method of Bligh and Dyer [5]. To separate out lipid 
classes, the lipid extracts were spotted onto silica gel coated thin layer chromatography plates and 
placed in a glass tank containing a solvent system of hexane:diethyl ether:acetic acid, in the ratio 
85:15:1 by volume. The lipid bands were visualised by spraying the glass plates with 0.1% solution 
(weight:volume)  of  8-anilino-1-napthalene  sulfonic  acid  and  viewing  them  under  ultraviolet  light. 
Serum cholesterol ester, phospholipid and triacylglycerol bands were scraped into glass test tubes and 
the fatty acids were converted into fatty acid methyl esters using 6% sulphuric acid in methanol and 
incubating at 80 ° C for 2 h, for cholesterol ester and triacylglycerol, and 12–16 h, for phospholipid. 
The samples were then eluted into hexane and stored at −20 ° C. 
An HP6890 Series Gas Chromatograph (Aligent, Palo Alto, CA) with a DB-225 megabore column 
(internal diameter: 30 m ×  0.25 mm; film thickness: 0.25 µ m; J & W Scientific, Deerfield, IL) and 
flame ionization detection was used to separate fatty acids. Blank extractions were analysed to correct 
for background contamination. Throughout the analysis, precision was monitored by analysing one 
pooled serum sample for every 20 NNS97 samples. The coefficients of variation (CVs) for the fatty 
acid  analysis  were  below  15%  for  the  vast  majority  of  fatty  acids  in  serum  cholesterol  ester, 
phospholipid and triacylglycerol (Table 1). The fatty acids are reported as molecular percents (mol%). 
2.3. Statistial Analysis 
STATA  (version  9.0;  Stata  Corp,  College  Station,  TX)  was  used  for  all  statistical  analyses. 
Differences in  the distribution of variables between the  NNS97  participants  who had  a  fatty acid 
measurement of at least one of serum cholesterol ester, phospholipid, or triacylglycerol, and NNS97 
participants  who  did  not  have  a  fatty  acid  measurement,  were  tested  using  t-tests  for  continuous 
variables and chi-squared tests for categorical variables. The major fatty acids—for which greater than 
75% of the study population had a detectable value—in serum cholesterol ester, phospholipid and 
triacylglycerol are presented. For the serum fatty acid analyses, survey commands were used to take 
into account the complex survey design of the NNS97. The survey-adjusted mean (SD) as well as 
percentiles were calculated for each of the major fatty acids. 
   Nutrients 2011, 3  
 
 
155 
Table 1. Coefficients of Variation (CVs) for the serum fatty acid analysis. 
      CV 
      Fatty acid  Cholesterol ester  Phospholipid  Triacylgycerol 
SAFA 
  14:0  15.0%  22.7%  15.1% 
  15:0  12.0%  11.2%  15.0% 
  16:0  7.8%  7.5%  4.4% 
  18:0  15.4%  7.9%  12.8% 
  20:0  -  14.9%  - 
  22:0  -  12.8%  - 
  24:0  -  15.4%  - 
           
MUFA 
  16:1n-7  16.5%  23.2%  11.2% 
  18:1n-9  11.4%  4.4%  6.1% 
  20:1n-9  -  -  32.6% 
  24:1n-9  -  10.6%  - 
           
PUFA 
n-3 
18:3n-3  14.3%  10.6%  25.6% 
20:5n-3  16.5%  13.9%  18.9% 
22:5n-3  -  12.0%  - 
22:6n-3  25.4%  13.1%  22.5% 
         
n-6 
18:2n-6  3.0%  10.6%  4.0% 
18:3n-6  9.6%  -  17.3% 
20:3n-6  4.6%  9.5%  35.7% 
20:4n-6  4.9%  10.7%  21.6% 
22:4n-6  -  -  32.2% 
SAFA: saturated; MUFA: monounsaturated; PUFA: polyunsaturated.  
3. Results and Discussion  
In total, 7862 people—a response rate of 73.8%—participated in the NZHS. Of these participants, 
4636  completed  a  24  h  recall  for  the  NNS97,  and  69.5%  of  the  NNS97  participants  (n  =  3228) 
consented to blood samples. The fatty acid composition of serum cholesterol ester, phospholipid and 
triacylglycerol  was  analysed  for  2393,  2416,  and  2402  participants,  respectively.  The  fatty  acid 
composition of at least one of the serum lipid classes was obtained from 2793 participants. 
Participant  characteristics  are  presented  in  Table  2.  It  has  previously  been  reported  that  the 
1996/1997  sample  (n  =  7862)  was  similar  to  the  NNS97  sample  (n  =  4636)  with  respect  to  the 
distribution  of  sex,  age,  ethnicity,  marital  status,  labourforce  status  and  smoking  status  [3].  The 
P values presented in Table 2 are from tests comparing the characteristics of the NNS97 participants 
who  had  the  fatty  acid  composition  of  at  least  one  of  serum  cholesterol  ester,  phospholipid,  or 
triacylglycerol  measured,  and  the  NNS97  participants  that  did  not  have  any  serum  fatty  acid 
measurement. There were small but statistically significant differences in the distribution of sex, age, 
ethnicity,  and  BMI  between  NNS97  participants  who  had  a  fatty  acid  measurement  and  NNS97 
participants who did not. There were no significant differences in smoking status, serum cholesterol Nutrients 2011, 3  
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concentrations, or in the intakes of dietary fat between these two groups. Most of the participants were 
between the ages of 25 to 44 years. Approximately one third of the participants were overweight, with 
an additional fifth classified as obese. Just over a quarter of the participants were current smokers. 
Sixteen percent of participants reported consuming fish in the previous 24 h. Dairy fat accounted for 
20% of the total dietary fat (data not shown). Fat intakes and major food sources of fat did not differ 
between participants who had a fatty acid value and participants who did not (Table 2).  
Table 2. Characteristics of the participants of the 1996/1997 NZHS and the 1997 National 
Nutrition Survey. 
      NNS97 participants     
 
1996/1997 
NZHS 
NNS97 
participants 
Fatty acid 
measurement 
1 
No fatty acid 
measurement 
  P 
2 
n (%) of 
1996/1997 NZHS 
7862 (100.0)  4636 (59.0)  2793 (35.5)  1843 (23.4)     
             
Females  4604 (58.6)  2709 (58.4)  1547 (55.4)  1162 (63.0)    <0.001 
             
Age category (y)             
15 to 18  405 (5.2)  246 (5.3)  122 (4.4)  124 (6.7)     
19 to 24  645 (8.2)  354 (7.6)  210 (7.5)  144 (7.8)     
25 to 44  3221 (41.0)  1964 (42.4)  1227 (43.9)  737 (40.0)    0.001 
45 to 64  2063 (26.2)  1255 (27.1)  765 (27.4)  490 (26.6)     
65+  1528 (19.4)  817 (17.6)  469 (16.8)  348 (18.9)     
             
Ethnicity             
NZEO  5896 (75.0)  3626 (78.2)  2286 (81.8)  1340 (72.7)     
NZ Maori  1321 (16.8)  703 (15.2)  368 (13.2)  335 (18.2)    <0.001 
Pacific people  646 (8.2)  307 (6.6)  139 (5.0)  168 (9.1)     
             
BMI category             
Normal  -  1882 (40.6)  1189 (42.6)  693 (37.6)   
<0.001 
Overweight  -  1530 (33.0)  999 (35.8)  531 (28.8)   
Obese  -  967 (20.9)  551 (19.7)  416 (22.6)   
Not measured  -  257 (5.5)  54 (1.9)  203 (11.0)   
             
Current smokers  2280 (29.0)  1258 (27.1)  763 (27.3)  495 (26.9)    0.730 
             
Total cholesterol 
(mmol/L) 
3 
-  5.8 (1.2)  5.8 (1.2)  5.8 (1.2)    0.6876 
             
HDL cholesterol 
(mmol/L) 
3 
-  1.3 (0.4)  1.3 (0.4)  1.3 (0.4)    0.5642 
             
   Nutrients 2011, 3  
 
 
157 
Table 2. Cont. 
Dietary fat intake (% of kJ) 
3             
Total fat  -  34.27 (11.90)  34.41 (8.74)  34.32 (9.12)    0.7416 
Saturated fat  -  14.68 (5.10)  14.72 (5.01)  14.61 (5.22)    0.4845 
Dairy fat  -  7.38 (6.87)  7.49 (6.88)  7.23 (6.84)    0.2173 
Monounsaturated fat  -  11.37 (3.62)  11.38 (3.55)  11.37 (3.71)    0.9575 
Polyunsaturated fat  -  4.85 (2.49)  4.83 (2.47)  4.87 (2.52)    0.6573 
Fish fat  -  0.62 (2.45)  0.61 (2.33)  0.64 (2.63)    0.6582 
NZHS,  New  Zealand  Health  Survey;  NNS97,  New  Zealand  National  Nutrition  Survey;  
CE, cholesterol ester; PL, phospholipid; TAG, triacylglycerol; NZEO, New Zealand European or 
other; NZ, New Zealand;  
1 NNS97 participants who had the fatty acid composition of at least one of serum cholesterol ester, 
phospholipid or triacylglycerol measured; 
2 For the difference between NNS97 participants who 
had a fatty acid value (n = 2793) and those who did not (n = 1843). Differences were tested using 
chi-squared  tests  for  categorical  variables  and  t-tests  for  continuous  variables;  Values  are 
number (%) unless otherwise indicated; 
3 Mean (SD). 
Tables 3, 4 and 5 report the fatty acid composition of serum cholesterol ester, phospholipid and 
triacylglycerol as means (SD) and percentiles. We describe the following fatty acid results: myristic 
acid (14:0) and pentadecanoic acid (15:0) as they are good biomarkers of dairy and saturated fat 
intake; linoleic acid (18:2n-6) as it is the major polyunsaturated fatty acid in the diet and in serum;  
and  the  major  long  chain  n-3  polyunsaturated  fatty  acids,  eicosapentaenoic  acid  (20:5n-3)  and 
docosahexaenoic acid (22:6n-3). 
The proportion of myristic acid was highest in serum triacylglycerol followed by serum cholesterol 
ester and phospholipid. The median (10th and 90th percentile) of myristic acid in serum triacylglycerol 
was 3.36 mol% (1.83 and 5.67 mol%), 1.01 mol% (0.61 and 1.57 mol%) in cholesterol ester, and  
0.50 mol% (0.33 and 0.72 mol%) in phospholipid. 
Pentadecanoic acid was present in smaller amounts than myristic acid in all three lipid classes. The 
median  (10th  and  90th  percentile)  of  pentadecanoic  acid  was  highest  in  serum  triacylglycerol  at  
0.51 mol% (0.33 and 0.80 mol%) and similar in phospholipid and cholesterol ester at 0.29 (0.20 and 
0.39 mol%) and 0.28 mol% (0.19 and 0.40 mol%), respectively. 
Linoleic acid was the major fatty acid in serum cholesterol ester, and the major polyunsaturated 
fatty acid in phospholipid and triacylglycerol. The median contribution (10th and 90th percentile) was 
50.30 mol% (41.02 and 57.42 mol%) in cholesterol ester, 19.25 mol% (14.56 and 23.31 mol%) in 
phospholipid, and 13.38 mol% (8.18 and 21.08 mol%) in triacylglycerol. 
The percentiles of eicosapentaenoic acid in serum cholesterol ester and phospholipid were similar 
with a median (10th and 90th percentile) value of 0.96 mol% (0.50 and 1.66 mol%) in cholesterol ester 
and 0.92 mol% (0.51 and 1.53 mol%) in phospholipid. The proportion of eicosapentaenoic acid in 
triacylglycerol  was  lower;  the  median  contribution  (10th  and  90th  percentile)  was  0.23  mol% 
(0.12 and 0.42 mol%). 
The median contribution of docosahexaenoic acid was highest in serum phospholipid at 2.55 mol% 
and  similar  in  cholesterol  ester  (0.48  mol%)  and  triacylglycerol  (0.42  mol%).  For  the  central 
80% (10th to 90th percentile) of the participants, docosahexaenoic acid contributed between 1.63 and Nutrients 2011, 3  
 
 
158 
3.70 mol%  for  phospholipid,  0.32  and  0.72  mol%  for  cholesterol  ester,  and  0.21  and  0.84  mol% 
for triacylglycerol. 
Table 3. National Nutrition Survey participant percentiles for serum cholesterol ester fatty 
acid composition. 
      Mean (SD)    Percentile 
    Fatty acid  n = 2393    5  10  25  50  75  90  95 
SAFA 
  14:0  1.05 (0.55)    0.51 
a  0.61  0.78  1.01  1.28  1.57  1.72 
  15:0  0.29 (0.13)    0.17  0.19  0.23  0.28  0.33  0.40  0.46 
  16:0  12.12 (2.86)    9.88  10.37  11.07  11.82  12.78  13.91  15.50 
  18:0  0.95 (0.42)    0.57  0.63  0.75  0.89  1.09  1.35  1.54 
                       
MUFA 
                     
  16:1n-7  4.35 (2.33)    2.00  2.41  3.13  4.03  5.26  6.70  7.89 
  18:1n-9  19.36 (4.54)    14.58  15.52  17.23  19.18  21.22  23.51  24.83 
                     
                       
PUFA 
n-6 
18:2n-6  49.58 (9.94)    37.08  41.02  46.00  50.30  54.01  57.42  59.82 
18:3n-6  1.04 (0.51)    0.48  0.58  0.76  0.98  1.28  1.59  1.77 
20:3n-6  0.67 (0.20)    0.46  0.49  0.57  0.66  0.76  0.87  0.94 
20:4n-6  5.58 (1.75)    3.59  3.98  4.70  5.49  6.39  7.21  7.84 
                     
n-3 
18:3n-3  0.76 (0.32)    0.45  0.50  0.60  0.73  0.89  1.05  1.17 
20:5n-3  1.03 (0.60)    0.42  0.50  0.70  0.96  1.28  1.66  1.91 
22:6n-3  0.50 (0.21)    0.28  0.32  0.38  0.48  0.59  0.72  0.80 
SAFA, saturated; MUFA, monounsaturated; PUFA, polyunsaturated;  
Mean (SD) and percentiles are survey adjusted;  
a Fatty acids are expressed as a molecular percent (mol%). 
Table 4. National Nutrition Survey participant percentiles for serum phospholipid fatty 
acid composition. 
      Mean (SD)    Percentile 
      Fatty acid  n = 2416     5  10  25  50  75  90  95 
SAFA 
  14:0  0.52 (0.24)    0.30 
a  0.33  0.41  0.50  0.60  0.72  0.80 
  15:0  0.29 (0.10)    0.18  0.20  0.24  0.29  0.34  0.39  0.41 
  16:0  31.73 (4.22)    28.41  28.98  29.96  31.06  32.78  35.02  37.56 
  18:0  14.34 (2.59)    11.95  12.49  13.22  14.05  15.06  16.42  17.79 
  20:0  0.55 (0.16)    0.38  0.42  0.48  0.54  0.61  0.69  0.75 
  22:0  1.54 (0.45)    1.08  1.18  1.32  1.50  1.72  1.95  2.11 
  24:0  1.28 (0.42)    0.89  0.96  1.08  1.23  1.42  1.64  1.80 
                       
MUFA 
  16:1n-7  0.83 (0.45)    0.38  0.47  0.59  0.78  1.01  1.27  1.43 
  18:1n-9  10.00 (2.51)    7.57  8.13  8.90  9.86  11.08  12.11  13.00 
  24:1n-9  1.73 (0.54)    1.09  1.26  1.47  1.71  1.99  2.21  2.42 
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Table 4. Cont. 
PUFA 
n-6 
18:2n-6  19.01 (5.22)    12.72  14.56  16.95  19.25  21.36  23.31  24.54 
20:3n-6  0.09 (0.08)    1.57  1.83  2.20  2.61  3.07  3.50  3.76 
20:4n-6  7.16 (2.19)    4.44  5.25  6.28  7.18  8.20  9.11  9.70 
                     
n-3 
18:3n-3  0.24 (0.12)    0.12  0.14  0.18  0.23  0.30  0.37  0.42 
20:5n-3  1.00 (0.60)    0.40  0.51  0.71  0.92  1.22  1.53  1.80 
22:5n-3  0.89 (0.32)    0.47  0.59  0.75  0.91  1.05  1.18  1.28 
22:6n-3  2.61 (1.07)    1.32  1.63  2.05  2.55  3.12  3.70  4.09 
SAFA, saturated; MUFA, monounsaturated; PUFA, polyunsaturated; 
Mean (SD) and percentiles are survey adjusted; 
a Fatty acids are expressed as a molecular percent (mol%). 
Table 5. National Nutrition Survey participant percentiles for serum triacylglycerol fatty 
acid composition. 
      Mean (SD)    Percentile 
    Fatty acid  n = 2402    5  10  25  50  75  90  95 
SAFA 
  14:0  3.62 (2.33)    1.43 
a  1.83  2.48  3.36  4.48  5.67  6.53 
  15:0  0.54 (0.34)    0.29  0.33  0.41  0.51  0.65  0.80  0.87 
  16:0  29.22 (5.77)    23.00  24.40  26.63  29.02  31.53  34.01  36.03 
  18:0  4.89 (2.40)    2.88  3.25  3.79  4.61  5.65  6.94  7.86 
  20:0  0.09 (0.25)    0.00  0.00 
b  0.05  0.07  0.10  0.15  0.18 
                       
MUFA 
  16:1n-7  4.82 (2.28)    2.43  2.91  3.67  4.67  5.83  6.94  7.72 
  18:1n-9  34.36 (5.90)    28.03  29.65  32.05  34.43  37.01  39.22  40.84 
  20:1n-9  0.24 (0.17)    0.00 
c  0.14  0.19  0.24  0.29  0.34  0.38 
                       
PUFA 
n-6 
18:2n-6  14.15 (7.65)    6.96  8.18  10.32  13.38  17.28  21.08  24.02 
18:3n-6  0.38 (0.32)    0.13  0.18  0.24  0.34  0.46  0.64  0.75 
20:3n-6  0.32 (0.45)    0.12  0.15  0.20  0.26  0.35  0.47  0.61 
20:4n-6  1.03 (0.75)    0.48  0.57  0.72  0.93  1.21  1.61  1.88 
22:4n-6  0.12 (0.28)    0.00 
d  0.05  0.08  0.10  0.13  0.16  0.20 
                     
n-3 
18:3n-3  0.98 (0.95)    0.27  0.43  0.66  0.91  1.19  1.48  1.75 
20:5n-3  0.26 (0.22)    0.10  0.12  0.17  0.23  0.31  0.42  0.52 
22:6n-3  0.50 (0.55)    0.16  0.21  0.29  0.42  0.59  0.84  1.08 
SAFA, saturated; MUFA, monounsaturated; PUFA, polyunsaturated;  
Mean (SD) and percentiles are survey adjusted;  
a Fatty acids are expressed as a molecular percent (mol%);  
b 9% of participants had values under the detectable limit;  
c 5% of participants had values under the detectable limit;  
d 6% of participants had values under the detectable limit. 
The results of this study describe the distribution of serum fatty acids, measured as percent of total 
fatty acids (mol%), in a large, randomly selected sample of adult New Zealanders. The percentiles of Nutrients 2011, 3  
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fatty  acids  in  serum  cholesterol  ester,  phospholipid  and  triacylglycerol  provide  population-based 
reference  ranges  against  which  the  fatty  acid  status  of  individuals  or  groups  can  be  compared.  
For  example,  with  percentile  reference  ranges  it  is  possible  to  judge  where  an  individual’s 
eicosapentaenoic acid level ranks relative to a population-based sample. It is our experience that these 
reference ranges will be useful to researchers and epidemiologists.  
Epidemiological studies which use fatty acids as biomarkers of dietary fat intake or disease risk 
commonly  measure  the  fatty  acid  composition  of  serum  or  plasma.  In  this  regard,  the  fatty  acid 
percentiles that we have described for serum are equally applicable to plasma given that Moilanen and 
Nikkari [6] found no difference in the fatty acid composition of serum or plasma. 
The distribution of serum fatty acids values in a population is influenced by a number of factors but 
clearly, the most important determinant is the range of dietary fat intakes in the population. These 
reference fatty acid percentiles are therefore relevant to other countries that have similar fat intakes to 
New  Zealanders.  This  includes—but  is  not  limited  to—populations  from  Australia,  the  United 
Kingdom and the United States; the results of recent national nutrition surveys in these countries 
indicate that  in adults  the saturated,  monounsaturated and polyunsaturated fat intakes  respectively 
contribute 13%, 12% and 5% of total energy in Australia [7], 12%, 12% and 6% of total energy in the 
United Kingdom [8] and 11%, 13% and 7% of total energy in the United States [9,10]. 
It is noteworthy that the mean serum fatty acid values from our population based data are similar to 
the average serum fatty acid composition reported by Hodson et al. [1]. The serum fatty acid values 
summarised by Hodson et al. [1] are drawn from studies carried out in a range of different countries, 
most of which used non-randomly selected convenience samples of participants. This indicates that the 
range in our population based fatty acid percentiles varies enough so as to be generalizable to a wide 
range of populations. Although it should be noted that countries which differ markedly from New 
Zealand in the proportion of saturates and unsaturates in the diet may have slightly different normative 
distributions for some serum fatty acids. For example, populations with high intakes of fish—such as 
the Japanese population—would be expected to have a higher proportion of serum n-3 long-chain 
polyunsaturated fatty acids.  
Non-dietary  factors—such  as  sex  [11–14],  age  [11,15],  smoking  [16–19],  adiposity  [12],  and 
exercise [20]—can also affect fatty acid composition. In comparison to diet, however, their influence 
is  minor  and  an  individual’s  sociodemographic  characteristics  would  not  appreciably  change  the 
interpretation of their fatty acid status. 
One of the main strengths of this study is that the participants were randomly selected from a 
nationwide sampling frame. There were some small differences in sociodemographic characteristics 
between the participants who had a fatty acid measurement and the participants who did not, but 
importantly, there were no differences in dietary fat intakes between these two groups. Thus, the serum 
fatty acid results are representative of the rest of the survey population. It is worth noting that the 
NNS97 participants provided non-fasting blood samples and that the precisions of measurement for 
some of the minor fatty acids were higher than 15%. In the postprandial state, the appearance of 
chylomicrons in systemic circulation can influence serum fatty acid composition; however, the effect 
of recent fat ingestion is largely confined to serum triacylglycerol fatty acids and the magnitude of 
change will depend on the amount of fat in the meal and to what extent the fat differs in composition 
from usual intake [21,22]. Whilst for an individual there may be discrepancies between the fat content Nutrients 2011, 3  
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of a recent meal and the usual diet, at a population level it will be similar. Thus, these factors should 
not  have  affected  the  mean  fatty  acid  values  but  may  have  broadened  the  distribution  across 
percentiles. Nevertheless, the results are relevant, particularly given that most large epidemiological 
studies, such as the European Prospective Investigation into Cancer and Nutrition and the UK Biobank 
study, also collect non-fasting blood samples for fatty acid analysis [23,24]. 
The choice of serum lipid class in which to measure fatty acids depends on a large number of 
factors. For example, is the purpose of the research to assess fat intake or to predict disease risk, to 
examine saturated fat intake or long chain n-3 polyunsaturated fatty acids? There is no one class of 
serum lipid that will serve all purposes; however, for particular outcomes some lipid classes may 
perform better than others. Some of these issues have been addressed elsewhere [1,25]. 
4. Conclusions  
This study is the first to present reference ranges for the fatty acid composition of the three most 
common serum lipid classes: cholesterol ester, phospholipid, and triacylglycerol from a large national 
survey which used population-based sampling techniques. These serum fatty acid percentile reference 
ranges will be a useful tool for researchers and epidemiologists in guiding the interpretation of the 
fatty acid status of adult study populations from a wide range of countries. 
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